These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 33901656)
1. Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy. Lagi F; Trevisan S; Piccica M; Graziani L; Basile G; Mencarini J; Borchi B; Menicacci L; Vaudo M; Scotti V; Fabbri A; Bandini G; Tozzetti C; Berni A; Aiezza N; Pestelli G; Turchi V; Pignone AM; Poggesi L; Nozzoli C; Morettini A; Rossolini GM; Bartoloni A Int J Infect Dis; 2021 Jul; 108():231-236. PubMed ID: 33901656 [TBL] [Abstract][Full Text] [Related]
2. Utility of the FebriDx point-of-care test for rapid triage and identification of possible coronavirus disease 2019 (COVID-19). Karim N; Ashraf MZ; Naeem M; Anwar T; Aung H; Mallik S; Avraam E; Kiran S; Bandapaati S; Khan F; Tsaknis G; Reddy R Int J Clin Pract; 2021 Mar; 75(3):e13702. PubMed ID: 32896946 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19. Clark TW; Brendish NJ; Poole S; Naidu VV; Mansbridge C; Norton N; Wheeler H; Presland L; Ewings S J Infect; 2020 Oct; 81(4):607-613. PubMed ID: 32579983 [TBL] [Abstract][Full Text] [Related]
4. Emergency Department point-of-care antiviral host response testing is accurate during periods of multiple respiratory virus co-circulation. Brendish NJ; Davis C; Chapman ME; Borca F; Waddington D; Hill C; White N; Clark TW J Infect; 2024 Jan; 88(1):41-47. PubMed ID: 37977337 [TBL] [Abstract][Full Text] [Related]
5. Utility of the FebriDx point-of-care assay in supporting a triage algorithm for medical admissions with possible COVID-19: an observational cohort study. Houston H; Deas G; Naik S; Shah K; Patel S; Greca Dottori M; Tay M; Filson SA; Biggin-Lamming J; Ross J; Vaughan N; Vaid N; Gopal Rao G; Amin AK; Gupta-Wright A; John L BMJ Open; 2021 Aug; 11(8):e049179. PubMed ID: 34373308 [TBL] [Abstract][Full Text] [Related]
6. A prospective, multi-centre US clinical trial to determine accuracy of FebriDx point-of-care testing for acute upper respiratory infections with and without a confirmed fever. Shapiro NI; Self WH; Rosen J; Sharp SC; Filbin MR; Hou PC; Parekh AD; Kurz MC; Sambursky R Ann Med; 2018 Aug; 50(5):420-429. PubMed ID: 29775092 [TBL] [Abstract][Full Text] [Related]
7. Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian emergency department with suspected COVID-19: an observational diagnostic accuracy study. Buntine P; Miller J; Pope A; Guy S; Wong FQA; McDonald H; Ahmed M; Teow KH; Roney M; Mohammadi F; Aldridge E; Hackett L; Jenner S; Davis B BMJ Open; 2022 Dec; 12(12):e065568. PubMed ID: 36581427 [TBL] [Abstract][Full Text] [Related]
8. FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department. Mansbridge CT; Tanner AR; Beard KR; Borca F; Phan HTT; Brendish NJ; Poole S; Hill C; Kiuber M; Crouch R; Waddington D; Clark TW Infect Control Hosp Epidemiol; 2022 Aug; 43(8):979-986. PubMed ID: 35094739 [TBL] [Abstract][Full Text] [Related]
9. Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study. Brendish NJ; Tanner AR; Poole S; Beard KR; Naidu VV; Mansbridge CT; Norton NJ; Wheeler H; Presland L; Clark TW Infect Dis Ther; 2022 Jun; 11(3):1267-1280. PubMed ID: 35534764 [TBL] [Abstract][Full Text] [Related]
10. FebriDx for rapid screening of patients with suspected COVID-19 upon hospital admission: systematic literature review and meta-analysis. Lippi G; Nocini R; Mattiuzzi C; Henry BM J Hosp Infect; 2022 May; 123():61-66. PubMed ID: 35202747 [TBL] [Abstract][Full Text] [Related]
11. Horses for courses? Assessing the potential value of a surrogate, point-of-care test for SARS-CoV-2 epidemic control. Ismail SA; Huntley C; Post N; Rigby S; Shrotri M; Williams SV; Peacock SJ Influenza Other Respir Viruses; 2021 Jan; 15(1):3-6. PubMed ID: 32767548 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections. Self WH; Rosen J; Sharp SC; Filbin MR; Hou PC; Parekh AD; Kurz MC; Shapiro NI J Clin Med; 2017 Oct; 6(10):. PubMed ID: 28991170 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy. Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505 [TBL] [Abstract][Full Text] [Related]
14. Performance of the FebriDx Rapid Point-of-Care Test for Differentiating Bacterial and Viral Respiratory Tract Infections in Patients with a Suspected Respiratory Tract Infection in the Emergency Department. Tong-Minh K; Daenen K; Endeman H; Ramakers C; Gommers D; van Gorp E; van der Does Y J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202172 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip. Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461 [TBL] [Abstract][Full Text] [Related]
16. Thoracic imaging tests for the diagnosis of COVID-19. Salameh JP; Leeflang MM; Hooft L; Islam N; McGrath TA; van der Pol CB; Frank RA; Prager R; Hare SS; Dennie C; Spijker R; Deeks JJ; Dinnes J; Jenniskens K; Korevaar DA; Cohen JF; Van den Bruel A; Takwoingi Y; van de Wijgert J; Damen JA; Wang J; ; McInnes MD Cochrane Database Syst Rev; 2020 Sep; 9():CD013639. PubMed ID: 32997361 [TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients. Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic. Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083 [TBL] [Abstract][Full Text] [Related]
19. Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France. Fitoussi F; Dupont R; Tonen-Wolyec S; Bélec L J Med Virol; 2021 Jul; 93(7):4351-4357. PubMed ID: 33738829 [TBL] [Abstract][Full Text] [Related]
20. Use of the FebriDx® host-response point-of-care test may reduce antibiotic use for respiratory tract infections in primary care: a mixed-methods feasibility study. Wilcox CR; Odeh N; Clark TW; Muller I; Becque T; Todd A; Islam N; Little P; Davies F; McGavin J; Francis N J Antimicrob Chemother; 2024 Jun; 79(6):1441-1449. PubMed ID: 38708643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]